Yes, you're possibly quite right. But I expect that if they had received all results, including re-assays, we'd have the scoping study on our screens or in our hands.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-21
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $7.825M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $3.294K | 529.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 15550004 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 5543633 | 7 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| ADG (ASX) Chart |